Issue

Vol. 13 (2021)

Nanoparticle–Cartilage Interaction: Pathology-Based Intra-articular Drug Delivery for Osteoarthritis Therapy

https://doi.org/10.1007/s40820-021-00670-y
Xu Li
Musculoskeletal Research Laboratory, Department of Orthopedics and Traumatology, The Chinese University of Hong Kong, Sha Tin, Hong Kong, SAR, People’s Republic of China
Bingyang Dai
Musculoskeletal Research Laboratory, Department of Orthopedics and Traumatology, The Chinese University of Hong Kong, Sha Tin, Hong Kong, SAR, People’s Republic of China
Jiaxin Guo
Musculoskeletal Research Laboratory, Department of Orthopedics and Traumatology, The Chinese University of Hong Kong, Sha Tin, Hong Kong, SAR, People’s Republic of China
Lizhen Zheng
Musculoskeletal Research Laboratory, Department of Orthopedics and Traumatology, The Chinese University of Hong Kong, Sha Tin, Hong Kong, SAR, People’s Republic of China
Quanyi Guo
Beijing Key Lab of Regenerative Medicine in Orthopedics, Key Laboratory of Musculoskeletal Trauma and War Injuries PLA, Institute of Orthopedics, Chinese PLA General Hospital, Beijing, People’s Republic of China
Jiang Peng
Beijing Key Lab of Regenerative Medicine in Orthopedics, Key Laboratory of Musculoskeletal Trauma and War Injuries PLA, Institute of Orthopedics, Chinese PLA General Hospital, Beijing, People’s Republic of China
Jiankun Xu
Musculoskeletal Research Laboratory, Department of Orthopedics and Traumatology, The Chinese University of Hong Kong, Sha Tin, Hong Kong, SAR, People’s Republic of China
Ling Qin
Musculoskeletal Research Laboratory, Department of Orthopedics and Traumatology, The Chinese University of Hong Kong, Sha Tin, Hong Kong, SAR, People’s Republic of China

Corresponding Author: Ling Qin

lingqin@cuhk.edu.hk

Nano-Micro Letters, Vol. 13 (2021), Article Number: 149

Abstract

Osteoarthritis is the most prevalent chronic and debilitating joint disease, resulting in huge medical and socioeconomic burdens. Intra-articular administration of agents is clinically used for pain management. However, the effectiveness is inapparent caused by the rapid clearance of agents. To overcome this issue, nanoparticles as delivery systems hold considerable promise for local control of the pharmacokinetics of therapeutic agents. Given the therapeutic programs are inseparable from pathological progress of osteoarthritis, an ideal delivery system should allow the release of therapeutic agents upon specific features of disorders. In this review, we firstly introduce the pathological features of osteoarthritis and the design concept for accurate localization within cartilage for sustained drug release. Then, we review the interactions of nanoparticles with cartilage microenvironment and the rational design. Furthermore, we highlight advances in the therapeutic schemes according to the pathology signals. Finally, armed with an updated understanding of the pathological mechanisms, we place an emphasis on the development of “smart” bioresponsive and multiple modality nanoparticles on the near horizon to interact with the pathological signals. We anticipate that the exploration of nanoparticles by balancing the efficacy, safety, and complexity will lay down a solid foundation tangible for clinical translation.


Highlights:


1 Nanoparticles hold considerable promise for controlling the local pharmacokinetics of therapeutic agents during osteoarthritis therapy.
2 The advantages of nanoparticles, the bioactive design, the transports and interactions within cartilage, and therapeutic mechanisms are discussed.
3 This review proposes future strategies to design more intelligent and multi-functional nanomaterials as delivery systems for cartilage therapy.

Keywords

Nanoparticle Drug delivery Osteoarthritis Articular cartilage Nanomedicine
Li, Xu, Bingyang Dai, Jiaxin Guo, Lizhen Zheng, Quanyi Guo, Jiang Peng, Jiankun Xu, and Ling Qin. 2021. “Nanoparticle–Cartilage Interaction: Pathology-Based Intra-Articular Drug Delivery for Osteoarthritis Therapy”. Nano-Micro Letters 13 (June):149. https://doi.org/10.1007/s40820-021-00670-y.
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. A.D. Woolf, B. Pfleger, Burden of major musculoskeletal conditions. Bull. World Health Organ. 81(9), 646–656 (2003)
  2. D.J. Hunter, D. Schofield, E. Callander, The individual and socioeconomic impact of osteoarthritis. Nat. Rev. Rheumatol. 10(7), 437–441 (2014). https://doi.org/10.1038/nrrheum.2014.44
  3. I.A. Jones, R. Togashi, M.L. Wilson, N. Heckmann, C.T. Vangsness Jr., Intra-articular treatment options for knee osteoarthritis. Nat. Rev. Rheumatol. 15(2), 77–90 (2019). https://doi.org/10.1038/s41584-018-0123-4
  4. K. Masuda, R.L. Sah, M.J. Hejna, E.J. Thonar, A novel two-step method for the formation of tissue-engineered cartilage by mature bovine chondrocytes: the alginate-recovered-chondrocyte (arc) method. J. Orthop. Res. 21(1), 139–148 (2003). https://doi.org/10.1016/s0736-0266(02)00109-2
  5. N. Verzijl, J. DeGroot, S.R. Thorpe, R.A. Bank, J.N. Shaw et al., Effect of collagen turnover on the accumulation of advanced glycation end products. J. Biol. Chem. 275(50), 39027–39031 (2000). https://doi.org/10.1074/jbc.M006700200
  6. A. Mobasheri, M.P. Rayman, O. Gualillo, J. Sellam, P. van der Kraan et al., The role of metabolism in the pathogenesis of osteoarthritis. Nat. Rev. Rheumatol. 13(5), 302–311 (2017). https://doi.org/10.1038/nrrheum.2017.50
  7. D.R. Eyre, M.A. Weis, J.J. Wu, Articular cartilage collagen: an irreplaceable framework? Eur. Cells Mater. 12, 57–63 (2006). https://doi.org/10.22203/ecm.v012a07
  8. S. Glyn-Jones, A.J. Palmer, R. Agricola, A.J. Price, T.L. Vincent et al., Osteoarthritis. Lancet 386(9991), 376–387 (2015). https://doi.org/10.1016/s0140-6736(14)60802-3
  9. Y. Deng, J. Lu, W. Li, A. Wu, X. Zhang et al., Reciprocal inhibition of YAP/TAZ and NF-κB regulates osteoarthritic cartilage degradation. Nat. Commun. 9(1), 4564 (2018). https://doi.org/10.1038/s41467-018-07022-2
  10. W. Tong, Y. Zeng, D.H.K. Chow, W. Yeung, J. Xu et al., Wnt16 attenuates osteoarthritis progression through a PCP/JNK-mTORC1-PTHrP cascade. Ann. Rheum.. Dis. 78(4), 551–561 (2019). https://doi.org/10.1136/annrheumdis-2018-214200
  11. W. Tong, Y. Geng, Y. Huang, Y. Shi, S. Xiang et al., In vivo identification and induction of articular cartilage stem cells by inhibiting NF-κB signaling in osteoarthritis. Stem Cells 33(10), 3125–3137 (2015). https://doi.org/10.1002/stem.2124
  12. J. Martel-Pelletier, C. Boileau, J.P. Pelletier, P.J. Roughley, Cartilage in normal and osteoarthritis conditions. Best Pract. Res. Clin. Rheumatol. 22(2), 351–384 (2008). https://doi.org/10.1016/j.berh.2008.02.001
  13. C.R. Flannery, C.B. Little, C.E. Hughes, B. Caterson, Expression of adamts homologues in articular cartilage. Biochem. Biophys. Res. Commun. 260(2), 318–322 (1999). https://doi.org/10.1006/bbrc.1999.0909
  14. C.D. DiDomenico, M. Lintz, L.J. Bonassar, Molecular transport in articular cartilage—what have we learned from the past 50 years? Nat. Rev. Rheumatol. 14(7), 393–403 (2018). https://doi.org/10.1038/s41584-018-0033-5
  15. D.J. Hunter, S. Bierma-Zeinstra, Osteoarthritis. Lancet 393(10182), 1745–1759 (2019). https://doi.org/10.1016/s0140-6736(19)30417-9
  16. L. Chen, F. Yao, T. Wang, G. Li, P. Chen et al., Horizontal fissuring at the osteochondral interface: a novel and unique pathological feature in patients with obesity-related osteoarthritis. Ann. Rheum. Dis. 79(6), 811–818 (2020). https://doi.org/10.1136/annrheumdis-2020-216942
  17. E.M. Bouta, R.D. Bell, H. Rahimi, L. Xing, R.W. Wood et al., Targeting lymphatic function as a novel therapeutic intervention for rheumatoid arthritis. Nat. Rev. Rheumatol. 14(2), 94–106 (2018). https://doi.org/10.1038/nrrheum.2017.205
  18. J.A. Block, Osteoarthritis: Oa guidelines: improving care or merely codifying practice? Nat. Rev. Rheumatol. 10(6), 324–326 (2014). https://doi.org/10.1038/nrrheum.2014.61
  19. T.E. McAlindon, R.R. Bannuru, M.C. Sullivan, N.K. Arden, F. Berenbaum et al., Oarsi guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartil. 22(3), 363–388 (2014). https://doi.org/10.1016/j.joca.2014.01.003
  20. B.R. da Costa, S. Reichenbach, N. Keller, L. Nartey, S. Wandel et al., Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis. Lancet 390(10090), e21–e33 (2017). https://doi.org/10.1016/s0140-6736(17)31744-0
  21. A.E. Nelson, K.D. Allen, Y.M. Golightly, A.P. Goode, J.M. Jordan, A systematic review of recommendations and guidelines for the management of osteoarthritis: the chronic osteoarthritis management initiative of the U.S. Bone and joint initiative. Semin. Arthritis Rheum. 43(6), 701–712 (2014). https://doi.org/10.1016/j.semarthrit.2013.11.012
  22. J. Martel-Pelletier, A.J. Barr, F.M. Cicuttini, P.G. Conaghan, C. Cooper et al., Osteoarthritis. Nat. Rev. Dis. Primers 2, 16072 (2016). https://doi.org/10.1038/nrdp.2016.72
  23. K. Zhao, Y.-S. Liu, L.-Y. Nie, L.-N. Qian, N.-F. Nie et al., The influence of sample size and gender composition on the meta-analysis conclusion of platelet-rich plasma treatment for osteoarthritis. J. Orthop. Transl. 22, 34–42 (2020). https://doi.org/10.1016/j.jot.2019.10.002
  24. N. Gerwin, C. Hops, A. Lucke, Intraarticular drug delivery in osteoarthritis. Adv. Drug Deliv. Rev. 58(2), 226–242 (2006). https://doi.org/10.1016/j.addr.2006.01.018
  25. C. Larsen, J. Ostergaard, S.W. Larsen, H. Jensen, S. Jacobsen et al., Intra-articular depot formulation principles: role in the management of postoperative pain and arthritic disorders. J. Pharm. Sci. 97(11), 4622–4654 (2008). https://doi.org/10.1002/jps.21346
  26. A. Ghadi, S. Mahjoub, F. Tabandeh, F. Talebnia, Synthesis and optimization of chitosan nanops: potential applications in nanomedicine and biomedical engineering. Caspian J. Int. Med. 5(3), 156–161 (2014)
  27. S. Gelperina, K. Kisich, M.D. Iseman, L. Heifets, The potential advantages of nanop drug delivery systems in chemotherapy of tuberculosis. Am. J. Respir. Crit. Care Med. 172(12), 1487–1490 (2005). https://doi.org/10.1164/rccm.200504-613PP
  28. H. Thakkar, R.K. Sharma, R.S. Murthy, Enhanced retention of celecoxib-loaded solid lipid nanops after intra-articular administration. Drugs R&D 8(5), 275–285 (2007). https://doi.org/10.2165/00126839-200708050-00002
  29. M. Higaki, T. Ishihara, N. Izumo, M. Takatsu, Y. Mizushima, Treatment of experimental arthritis with poly(d, l-lactic/glycolic acid) nanops encapsulating betamethasone sodium phosphate. Ann. Rheum. Dis. 64(8), 1132–1136 (2005). https://doi.org/10.1136/ard.2004.030759
  30. C.H. Evans, V.B. Kraus, L.A. Setton, Progress in intra-articular therapy. Nat. Rev. Rheumatol. 10(1), 11–22 (2014). https://doi.org/10.1038/nrrheum.2013.159
  31. J. Pradal, P. Maudens, C. Gabay, C.A. Seemayer, O. Jordan et al., Effect of p size on the biodistribution of nano- and microps following intra-articular injection in mice. Int. J. Pharm. 498(1–2), 119–129 (2016). https://doi.org/10.1016/j.ijpharm.2015.12.015
  32. A.G. Bajpayee, A.J. Grodzinsky, Cartilage-targeting drug delivery: can electrostatic interactions help? Nat. Rev. Rheumatol. 13(3), 183–193 (2017). https://doi.org/10.1038/nrrheum.2016.210
  33. B.D. Partain, M. Unni, C. Rinaldi, K.D. Allen, The clearance and biodistribution of magnetic composite nanops in healthy and osteoarthritic rat knees. J. Control. Release 321, 259–271 (2020). https://doi.org/10.1016/j.jconrel.2020.01.052
  34. Y. Wei, L. Luo, T. Gui, F. Yu, L. Yan et al., Targeting cartilage egfr pathway for osteoarthritis treatment. Sci. Transl. Med. 13(576), eabb3946 (2021). https://doi.org/10.1126/scitranslmed.abb3946
  35. A.J.S. Fox, A. Bedi, S.A. Rodeo, The basic science of articular cartilage: structure, composition, and function. Sports Health 1(6), 461–468 (2009). https://doi.org/10.1177/1941738109350438
  36. B.K. Hall, S.A. Newman, Cartilage Molecular Aspects (CRC Press, 1991)
  37. D.A. Rothenfluh, H. Bermudez, C.P. O’Neil, J.A. Hubbell, Biofunctional polymer nanops for intra-articular targeting and retention in cartilage. Nat. Mater. 7(3), 248–254 (2008). https://doi.org/10.1038/nmat2116
  38. P.A. Torzilli, J.M. Arduino, J.D. Gregory, M. Bansal, Effect of proteoglycan removal on solute mobility in articular cartilage. J. Biomech. 30(9), 895–902 (1997). https://doi.org/10.1016/s0021-9290(97)00059-6
  39. K.A. Elsaid, L. Ferreira, T. Truong, A. Liang, J. Machan et al., Pharmaceutical nanocarrier association with chondrocytes and cartilage explants: influence of surface modification and extracellular matrix depletion. Osteoarthritis Cartil. 21(2), 377–384 (2013). https://doi.org/10.1016/j.joca.2012.11.011
  40. B.C. Geiger, S. Wang, R.F. Padera Jr., A.J. Grodzinsky, P.T. Hammond, Cartilage-penetrating nanocarriers improve delivery and efficacy of growth factor treatment of osteoarthritis. Sci. Transl. Med. 10(469), eaat8800 (2018). https://doi.org/10.1126/scitranslmed.aat8800
  41. A.G. Bajpayee, C.R. Wong, M.G. Bawendi, E.H. Frank, A.J. Grodzinsky, Avidin as a model for charge driven transport into cartilage and drug delivery for treating early stage post-traumatic osteoarthritis. Biomaterials 35(1), 538–549 (2014). https://doi.org/10.1016/j.biomaterials.2013.09.091
  42. J. Malda, J.C. de Grauw, K.E. Benders, M.J. Kik, C.H. van de Lest et al., Of mice, men and elephants: the relation between articular cartilage thickness and body mass. PLoS ONE 8(2), e57683 (2013). https://doi.org/10.1371/journal.pone.0057683
  43. N. Kamisan, S.V. Naveen, R.E. Ahmad, T. Kamarul, Chondrocyte density, proteoglycan content and gene expressions from native cartilage are species specific and not dependent on cartilage thickness: a comparative analysis between rat, rabbit and goat. BMC Vet. Res. 9, 62 (2013). https://doi.org/10.1186/1746-6148-9-62
  44. M. Morgen, D. Tung, B. Boras, W. Miller, A.M. Malfait et al., Nanops for improved local retention after intra-articular injection into the knee joint. Pharm. Res. 30(1), 257–268 (2013). https://doi.org/10.1007/s11095-012-0870-x
  45. S. Brown, J. Pistiner, I.M. Adjei, B. Sharma, Nanop properties for delivery to cartilage: the implications of disease state, synovial fluid, and off-target uptake. Mol. Pharm. 16(2), 469–479 (2019). https://doi.org/10.1021/acs.molpharmaceut.7b00484
  46. J. Schlessinger, A.N. Plotnikov, O.A. Ibrahimi, A.V. Eliseenkova, B.K. Yeh et al., Crystal structure of a ternary fgf-fgfr-heparin complex reveals a dual role for heparin in fgfr binding and dimerization. Mol. Cell 6(3), 743–750 (2000). https://doi.org/10.1016/s1097-2765(00)00073-3
  47. L. Haglund, V. Tillgren, P. Onnerfjord, D. Heinegard, The c-terminal peptide of chondroadherin modulates cellular activity by selectively binding to heparan sulfate chains. J. Biol. Chem. 288(2), 995–1008 (2013). https://doi.org/10.1074/jbc.M112.430512
  48. T. Tokunou, R. Miller, P. Patwari, M.E. Davis, V.F. Segers et al., Engineering insulin-like growth factor-1 for local delivery. FASEB J. 22(6), 1886–1893 (2008). https://doi.org/10.1096/fj.07-100925
  49. R.E. Miller, A.J. Grodzinsky, K. Cummings, A.H.K. Plaas, A.A. Cole et al., Intraarticular injection of heparin-binding insulin-like growth factor 1 sustains delivery of insulin-like growth factor 1 to cartilage through binding to chondroitin sulfate. Arthritis Rheum. 62(12), 3686–3694 (2010). https://doi.org/10.1002/art.27709
  50. F.S. Loffredo, J.R. Pancoast, L. Cai, T. Vannelli, J.Z. Dong et al., Targeted delivery to cartilage is critical for in vivo efficacy of insulin-like growth factor 1 in a rat model of osteoarthritis. Arthritis Rheum. 66(5), 1247–1255 (2014). https://doi.org/10.1002/art.38357
  51. H. Cho, J.M. Stuart, R. Magid, D.C. Danila, T. Hunsaker et al., Theranostic immunoliposomes for osteoarthritis. Nanomed.-Nanotechnol. Biol. Med. 10(3), 619–627 (2014). https://doi.org/10.1016/j.nano.2013.09.004
  52. J. Hwang, Y. Huang, T.J. Burwell, N.C. Peterson, J. Connor, S.J. Weiss, S.M. Yu, Y. Li, In situ imaging of tissue remodeling with collagen hybridizing peptides. ACS Nano 11(10), 9825–9835 (2017). https://doi.org/10.1021/acsnano.7b03150
  53. H. Chen, Z. Qin, J. Zhao, Y. He, E. Ren et al., Cartilage-targeting and dual mmp-13/ph responsive theranostic nanoprobes for osteoarthritis imaging and precision therapy. Biomaterials 225, 119520 (2019). https://doi.org/10.1016/j.biomaterials.2019.119520
  54. S.B. Brown, L. Wang, R.R. Jungels, B. Sharma, Effects of cartilage-targeting moieties on nanop biodistribution in healthy and osteoarthritic joints. Acta Biomater. 101, 469–483 (2020). https://doi.org/10.1016/j.actbio.2019.10.003
  55. T.M. Quinn, A.A. Maung, A.J. Grodzinsky, E.B. Hunziker, J.D. Sandy, Physical and biological regulation of proteoglycan turnover around chondrocytes in cartilage explants. Implications for tissue degradation and repair. Ann. N. Y. Acad. Sci. 878, 420–441 (1999). https://doi.org/10.1111/j.1749-6632.1999.tb07700.x
  56. C.A. Poole, A. Matsuoka, J.R. Schofield, Chondrons from articular cartilage. Iii. Morphologic changes in the cellular microenvironment of chondrons isolated from osteoarthritic cartilage. Arthritis Rheum. 34(1), 22–35 (1991). https://doi.org/10.1002/art.1780340105
  57. H. Laroui, L. Grossin, M. Léonard, J.F. Stoltz, P. Gillet et al., Hyaluronate-covered nanops for the therapeutic targeting of cartilage. Biomacromol 8(12), 3879–3885 (2007). https://doi.org/10.1021/bm700836y
  58. C.B. Knudson, W. Knudson, Hyaluronan and cd44: modulators of chondrocyte metabolism. Clin. Orthop. Relat. Res. 427(Suppl), S152-162 (2004)
  59. Z. Chen, J. Chen, L. Wu, W. Li, J. Chen et al., Hyaluronic acid-coated bovine serum albumin nanops loaded with brucine as selective nanovectors for intra-articular injection. Int. J. Nanomed. 8, 3843–3853 (2013). https://doi.org/10.2147/IJN.S50721
  60. N.D. Donahue, H. Acar, S. Wilhelm, Concepts of nanop cellular uptake, intracellular trafficking, and kinetics in nanomedicine. Adv. Drug Deliv. Rev. 143, 68–96 (2019). https://doi.org/10.1016/j.addr.2019.04.008
  61. W. He, X. Xing, X. Wang, D. Wu, W. Wu et al., Nanocarrier-mediated cytosolic delivery of biopharmaceuticals. Adv. Funct. Mater. 30, 1910566 (2020). https://doi.org/10.1002/adfm.201910566
  62. A.K. Gaharwar, I. Singh, A. Khademhosseini, Engineered biomaterials for in situ tissue regeneration. Nat. Rev. Mater. 5, 686–705 (2020). https://doi.org/10.1038/s41578-020-0209-x
  63. B.C. te Boekhorst, L.B. Jensen, S. Colombo, A.K. Varkouhi, R.M. Schiffelers et al., Mri-assessed therapeutic effects of locally administered plga nanops loaded with anti-inflammatory sirna in a murine arthritis model. J. Control. Release 161(3), 772–780 (2012). https://doi.org/10.1016/j.jconrel.2012.05.004
  64. J.S. Park, H.N. Yang, S.Y. Jeon, D.G. Woo, M.S. Kim et al., The use of anti-COX2 sirna coated onto plga nanops loading dexamethasone in the treatment of rheumatoid arthritis. Biomaterials 33(33), 8600–8612 (2012). https://doi.org/10.1016/j.biomaterials.2012.08.008
  65. Y. Wang, P. Li, L. Kong, Chitosan-modified plga nanops with versatile surface for improved drug delivery. AAPS PharmSciTech 14(2), 585–592 (2013). https://doi.org/10.1208/s12249-013-9943-3
  66. N. Nafee, S. Taetz, M. Schneider, U.F. Schaefer, C.M. Lehr, Chitosan-coated plga nanops for DNA/rna delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides. Nanomedicine 3(3), 173–183 (2007). https://doi.org/10.1016/j.nano.2007.03.006
  67. F. Esmaeili, M.H. Ghahremani, S.N. Ostad, F. Atyabi, M. Seyedabadi et al., Folate-receptor-targeted delivery of docetaxel nanops prepared by plga-peg-folate conjugate. J. Drug Target. 16(5), 415–423 (2008). https://doi.org/10.1080/10611860802088630
  68. K. Zhang, X. Tang, J. Zhang, W. Lu, X. Lin et al., Peg-plga copolymers: their structure and structure-influenced drug delivery applications. J. Control. Release 183, 77–86 (2014). https://doi.org/10.1016/j.jconrel.2014.03.026
  69. J.S. Suk, Q. Xu, N. Kim, J. Hanes, L.M. Ensign, Pegylation as a strategy for improving nanop-based drug and gene delivery. Adv. Drug Deliv. Rev. 99(Pt A), 28–51 (2016). https://doi.org/10.1016/j.addr.2015.09.012
  70. M. Fathi-Achachelouei, D. Keskin, E. Bat, N.E. Vrana, A. Tezcaner, Dual growth factor delivery using plga nanops in silk fibroin/pegdma hydrogels for articular cartilage tissue engineering. J. Biomed. Mater. Res. Part B 108(5), 2041–2062 (2020). https://doi.org/10.1002/jbm.b.34544
  71. J.H. Kim, J.S. Park, H.N. Yang, D.G. Woo, S.Y. Jeon et al., The use of biodegradable PLGA nanops to mediate SOX9 gene delivery in human mesenchymal stem cells (hMSCs) and induce chondrogenesis. Biomaterials 32(1), 268–278 (2011). https://doi.org/10.1016/j.biomaterials.2010.08.086
  72. Y.N. Tan, P.P. Lee, W.N. Chen, Microbial extraction of chitin from seafood waste using sugars derived from fruit waste-stream. AMB Express 10(1), 17–17 (2020). https://doi.org/10.1186/s13568-020-0954-7
  73. R. Jayakumar, K.P. Chennazhi, S. Srinivasan, S.V. Nair, T. Furuike et al., Chitin scaffolds in tissue engineering. Int. J. Mol. Sci. 12(3), 1876–1887 (2011). https://doi.org/10.3390/ijms12031876
  74. R.C.F. Cheung, T.B. Ng, J.H. Wong, W.Y. Chan, Chitosan: an update on potential biomedical and pharmaceutical applications. Mar. Drugs 13(8), 5156–5186 (2015). https://doi.org/10.3390/md13085156
  75. H. Tan, C.R. Chu, K.A. Payne, K.G. Marra, Injectable in situ forming biodegradable chitosan-hyaluronic acid based hydrogels for cartilage tissue engineering. Biomaterials 30(13), 2499–2506 (2009). https://doi.org/10.1016/j.biomaterials.2008.12.080
  76. C. Manferdini, E. Gabusi, L. Sartore, K. Dey, S. Agnelli et al., Chitosan-based scaffold counteracts hypertrophic and fibrotic markers in chondrogenic differentiated mesenchymal stromal cells. J. Tissue Eng. Regen. Med. 13(10), 1896–1911 (2019). https://doi.org/10.1002/term.2941
  77. J.K. Suh, H.W. Matthew, Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering: a review. Biomaterials 21(24), 2589–2598 (2000). https://doi.org/10.1016/s0142-9612(00)00126-5
  78. M.M. Islam, M. Shahruzzaman, S. Biswas, M.N. Sakib, T.U. Rashid, Chitosan based bioactive materials in tissue engineering applications-a review. Bioact. Mater. 5(1), 164–183 (2020). https://doi.org/10.1016/j.bioactmat.2020.01.012
  79. K.Y. Lee, W.S. Ha, W.H. Park, Blood compatibility and biodegradability of partially n-acylated chitosan derivatives. Biomaterials 16(16), 1211–1216 (1995). https://doi.org/10.1016/0142-9612(95)98126-y
  80. H. Katas, M.A.G. Raja, K.L. Lam, Development of chitosan nanops as a stable drug delivery system for protein/siRNA. Int. J. Biomater. 2013, 146320–146320 (2013). https://doi.org/10.1155/2013/146320
  81. S. Mao, W. Sun, T. Kissel, Chitosan-based formulations for delivery of DNA and siRNA. Adv. Drug Deliv. Rev. 62(1), 12–27 (2010). https://doi.org/10.1016/j.addr.2009.08.004
  82. Y. Zhou, S.Q. Liu, H. Peng, L. Yu, B. He et al., In vivo anti-apoptosis activity of novel berberine-loaded chitosan nanops effectively ameliorates osteoarthritis. Int. Immunopharmacol. 28(1), 34–43 (2015). https://doi.org/10.1016/j.intimp.2015.05.014
  83. Q. Shi, E.P. Rondon-Cavanzo, I.P.D. Picola, M.J. Tiera, X. Zhang et al., In vivo therapeutic efficacy of tnfα silencing by folate-peg-chitosan-deae/siRNA nanops in arthritic mice. Int. J. Nanomed. 13, 387–402 (2018). https://doi.org/10.2147/ijn.S146942
  84. H. Lu, L. Lv, Y. Dai, G. Wu, H. Zhao et al., Porous chitosan scaffolds with embedded hyaluronic acid/chitosan/plasmid-DNA nanops encoding TGF-β1 induce DNA controlled release, transfected chondrocytes, and promoted cell proliferation. PLoS ONE 8(7), e69950 (2013). https://doi.org/10.1371/journal.pone.0069950
  85. S.J. Lee, A. Lee, S.R. Hwang, J.S. Park, J. Jang et al., TNF-α gene silencing using polymerized siRNA/thiolated glycol chitosan nanops for rheumatoid arthritis. Mol. Ther. 22(2), 397–408 (2014). https://doi.org/10.1038/mt.2013.245
  86. E. Lallana, J.M. Rios de la Rosa, A. Tirella, M. Pelliccia, A. Gennari et al., Chitosan/hyaluronic acid nanops: rational design revisited for rna delivery. Mol. Pharm. 14(7), 2422–2436 (2017). https://doi.org/10.1021/acs.molpharmaceut.7b00320
  87. P.H. Zhou, B. Qiu, R.H. Deng, H.J. Li, X.F. Xu et al., Chondroprotective effects of hyaluronic acid-chitosan nanops containing plasmid DNA encoding cytokine response modifier a in a rat knee osteoarthritis model. Cell. Physiol. Biochem. 47(3), 1207–1216 (2018). https://doi.org/10.1159/000490217
  88. Y. Cao, Y.F. Tan, Y.S. Wong, M.W.J. Liew, S. Venkatraman, Recent advances in chitosan-based carriers for gene delivery. Mar. Drugs 17(6), 381 (2019). https://doi.org/10.3390/md17060381
  89. X. Ji, Y. Yan, T. Sun, Q. Zhang, Y. Wang et al., Glucosamine sulphate-loaded distearoyl phosphocholine liposomes for osteoarthritis treatment: combination of sustained drug release and improved lubrication. Biomater. Sci. 7(7), 2716–2728 (2019). https://doi.org/10.1039/c9bm00201d
  90. J.M. van den Hoven, S.R. Van Tomme, J.M. Metselaar, B. Nuijen, J.H. Beijnen et al., Liposomal drug formulations in the treatment of rheumatoid arthritis. Mol. Pharm. 8(4), 1002–1015 (2011). https://doi.org/10.1021/mp2000742
  91. S. Sivan, A. Schroeder, G. Verberne, Y. Merkher, D. Diminsky et al., Liposomes act as effective biolubricants for friction reduction in human synovial joints. Langmuir 26(2), 1107–1116 (2010). https://doi.org/10.1021/la9024712
  92. J. Dong, D. Jiang, Z. Wang, G. Wu, L. Miao et al., Intra-articular delivery of liposomal celecoxib-hyaluronate combination for the treatment of osteoarthritis in rabbit model. Int. J. Pharm. 441(1–2), 285–290 (2013). https://doi.org/10.1016/j.ijpharm.2012.11.031
  93. I. Elron-Gross, Y. Glucksam, R. Margalit, Liposomal dexamethasone-diclofenac combinations for local osteoarthritis treatment. Int. J. Pharm. 376(1–2), 84–91 (2009). https://doi.org/10.1016/j.ijpharm.2009.04.025
  94. F.H. Chen, K.T. Rousche, R.S. Tuan, Technology insight: adult stem cells in cartilage regeneration and tissue engineering. Nat. Clin. Pract. Rheumatol. 2(7), 373–382 (2006). https://doi.org/10.1038/ncprheum0216
  95. H. Watanabe, Y. Yamada, K. Kimata, Roles of aggrecan, a large chondroitin sulfate proteoglycan, in cartilage structure and function. J. Biochem. 124(4), 687–693 (1998). https://doi.org/10.1093/oxfordjournals.jbchem.a022166
  96. T.M. Tamer, Hyaluronan and synovial joint: function, distribution and healing. Interdiscip. Toxicol. 6(3), 111–125 (2013). https://doi.org/10.2478/intox-2013-0019
  97. R.C. Gupta, R. Lall, A. Srivastava, A. Sinha, Hyaluronic acid: molecular mechanisms and therapeutic trajectory. Front. Vet. Sci. 6, 192 (2019). https://doi.org/10.3389/fvets.2019.00192
  98. E. George, Intra-articular hyaluronan treatment for osteoarthritis. Ann. Rheum. Dis. 57(11), 637–640 (1998). https://doi.org/10.1136/ard.57.11.637
  99. P.A. Band, J. Heeter, H.G. Wisniewski, V. Liublinska, C.W. Pattanayak et al., Hyaluronan molecular weight distribution is associated with the risk of knee osteoarthritis progression. Osteoarthritis Cartil. 23(1), 70–76 (2015). https://doi.org/10.1016/j.joca.2014.09.017
  100. E.A. Balazs, J.L. Denlinger, Viscosupplementation: a new concept in the treatment of osteoarthritis. J. Rheumatol. Suppl. 39, 3–9 (1993)
  101. H.D. Lu, H.Q. Zhao, K. Wang, L.L. Lv, Novel hyaluronic acid-chitosan nanops as non-viral gene delivery vectors targeting osteoarthritis. Int. J. Pharm. 420(2), 358–365 (2011). https://doi.org/10.1016/j.ijpharm.2011.08.046
  102. M. Zhou, J. Hou, Z. Zhong, N. Hao, Y. Lin et al., Targeted delivery of hyaluronic acid-coated solid lipid nanops for rheumatoid arthritis therapy. Drug Deliv. 25(1), 716–722 (2018). https://doi.org/10.1080/10717544.2018.1447050
  103. H. Lu, Y. Dai, L. Lv, H. Zhao, Chitosan-graft-polyethylenimine/DNA nanops as novel non-viral gene delivery vectors targeting osteoarthritis. PLoS ONE 9(1), e84703 (2014). https://doi.org/10.1371/journal.pone.0084703
  104. S. Nedvetzki, M. Walmsley, E. Alpert, R.O. Williams, M. Feldmann et al., Cd44 involvement in experimental collagen-induced arthritis (CIA). J. Autoimmun. 13(1), 39–47 (1999). https://doi.org/10.1006/jaut.1999.0294
  105. G.M. Campo, A. Avenoso, S. Campo, A. D’Ascola, G. Nastasi et al., Small hyaluronan oligosaccharides induce inflammation by engaging both toll-like-4 and CD44 receptors in human chondrocytes. Biochem. Pharmacol. 80(4), 480–490 (2010). https://doi.org/10.1016/j.bcp.2010.04.024
  106. F.J. Zhang, S.G. Gao, L. Cheng, J. Tian, W.S. Xu et al., The effect of hyaluronic acid on osteopontin and CD44 mrna of fibroblast-like synoviocytes in patients with osteoarthritis of the knee. Rheumatol. Int. 33(1), 79–83 (2013). https://doi.org/10.1007/s00296-011-2339-3
  107. P. Maudens, S. Meyer, C.A. Seemayer, O. Jordan, E. Allémann, Self-assembled thermoresponsive nanostructures of hyaluronic acid conjugates for osteoarthritis therapy. Nanoscale 10(4), 1845–1854 (2018). https://doi.org/10.1039/c7nr07614b
  108. J.E. Rowley, F. Amargant, L.T. Zhou, A. Galligos, L.E. Simon et al., Low molecular weight hyaluronan induces an inflammatory response in ovarian stromal cells and impairs gamete development in vitro. Int. J. Mol. Sci. 21(3), 1036 (2020). https://doi.org/10.3390/ijms21031036
  109. J. Monfort, J.P. Pelletier, N. Garcia-Giralt, J. Martel-Pelletier, Biochemical basis of the effect of chondroitin sulphate on osteoarthritis articular tissues. Ann. Rheum. Dis. 67(6), 735–740 (2008). https://doi.org/10.1136/ard.2006.068882
  110. R.M. Lauder, Chondroitin sulphate: a complex molecule with potential impacts on a wide range of biological systems. Complement. Ther. Med. 17(1), 56–62 (2009). https://doi.org/10.1016/j.ctim.2008.08.004
  111. P.J. Roughley, The structure and function of cartilage proteoglycans. Eur. Cells Mater. 12, 92–101 (2006). https://doi.org/10.22203/ecm.v012a11
  112. U.P. Palukuru, C.M. McGoverin, N. Pleshko, Assessment of hyaline cartilage matrix composition using near infrared spectroscopy. Matrix Biol. 38, 3–11 (2014). https://doi.org/10.1016/j.matbio.2014.07.007
  113. L. Bian, M. Kaplun, D.Y. Williams, D. Xu, G.A. Ateshian et al., Influence of chondroitin sulfate on the biochemical, mechanical and frictional properties of cartilage explants in long-term culture. J. Biomech. 42(3), 286–290 (2009). https://doi.org/10.1016/j.jbiomech.2008.10.032
  114. A.I. Maroudas, Balance between swelling pressure and collagen tension in normal and degenerate cartilage. Nature 260(5554), 808–809 (1976). https://doi.org/10.1038/260808a0
  115. M. David-Raoudi, B. Deschrevel, S. Leclercq, P. Galera, K. Boumediene et al., Chondroitin sulfate increases hyaluronan production by human synoviocytes through differential regulation of hyaluronan synthases: role of p38 and akt. Arthritis Rheum. 60(3), 760–770 (2009). https://doi.org/10.1002/art.24302
  116. Q.G. Wang, A.J. El. Haj, N.J. Kuiper, Glycosaminoglycans in the pericellular matrix of chondrons and chondrocytes. J. Anat. 213(3), 266–273 (2008). https://doi.org/10.1111/j.1469-7580.2008.00942.x
  117. M. Bishnoi, A. Jain, P. Hurkat, S.K. Jain, Chondroitin sulphate: a focus on osteoarthritis. Glycoconjugate J. 33(5), 693–705 (2016). https://doi.org/10.1007/s10719-016-9665-3
  118. V. Calamia, L. Lourido, P. Fernandez-Puente, J. Mateos, B. Rocha et al., Secretome analysis of chondroitin sulfate-treated chondrocytes reveals anti-angiogenic, anti-inflammatory and anti-catabolic properties. Arthritis Res. Ther. 14(5), R202 (2012). https://doi.org/10.1186/ar4040
  119. D. Ishimaru, N. Sugiura, H. Akiyama, H. Watanabe, K. Matsumoto, Alterations in the chondroitin sulfate chain in human osteoarthritic cartilage of the knee. Osteoarthritis Cartil. 22(2), 250–258 (2014). https://doi.org/10.1016/j.joca.2013.11.010
  120. Y.K. Jung, H.R. Park, H.J. Cho, J.A. Jang, E.J. Lee et al., Degrading products of chondroitin sulfate can induce hypertrophy-like changes and MMP-13/ADAMTS5 production in chondrocytes. Sci. Rep. 9(1), 15846 (2019). https://doi.org/10.1038/s41598-019-52358-4
  121. K.M. Jordan, N.K. Arden, M. Doherty, B. Bannwarth, J.W. Bijlsma et al., Eular recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a task force of the standing committee for international clinical studies including therapeutic trials (escisit). Ann. Rheum. Dis. 62(12), 1145–1155 (2003). https://doi.org/10.1136/ard.2003.011742
  122. A. Jain, S.K. Mishra, P.R. Vuddanda, S.K. Singh, R. Singh et al., Targeting of diacerein loaded lipid nanops to intra-articular cartilage using chondroitin sulfate as homing carrier for treatment of osteoarthritis in rats. Nanomed.-Nanotechnol. Biol. Med. 10(5), 1031–1040 (2014). https://doi.org/10.1016/j.nano.2014.01.008
  123. X.F. Yin, L.L. Wang, X.C. Chu, A novel chondroitin sulfate decorated nano platinum for the treatment of osteoarthritis. Mater. Sci. Eng. C-Mater. Biol. Appl. 78, 452–456 (2017). https://doi.org/10.1016/j.msec.2017.04.028
  124. F. Bakilan, O. Armagan, M. Ozgen, F. Tascioglu, O. Bolluk et al., Effects of native type ii collagen treatment on knee osteoarthritis: a randomized controlled trial. Eurasian J. Med. 48(2), 95–101 (2016). https://doi.org/10.5152/eurasianjmed.2015.15030
  125. C. Lian, X. Wang, X. Qiu, Z. Wu, B. Gao et al., Collagen type ii suppresses articular chondrocyte hypertrophy and osteoarthritis progression by promoting integrin β1-smad1 interaction. Bone Res. (2019). https://doi.org/10.1038/s41413-019-0046-y
  126. G.S. Hussey, J.L. Dziki, S.F. Badylak, Extracellular matrix-based materials for regenerative medicine. Nat. Rev. Mater. 3(7), 159–173 (2018). https://doi.org/10.1038/s41578-018-0023-x
  127. K.E. Benders, P.R. van Weeren, S.F. Badylak, D.B. Saris, W.J. Dhert et al., Extracellular matrix scaffolds for cartilage and bone regeneration. Trends Biotechnol. 31(3), 169–176 (2013). https://doi.org/10.1016/j.tibtech.2012.12.004
  128. X. Li, W. Guo, K. Zha, X. Jing, M. Wang et al., Enrichment of CD146(+) adipose-derived stem cells in combination with articular cartilage extracellular matrix scaffold promotes cartilage regeneration. Theranostics 9(17), 5105–5121 (2019). https://doi.org/10.7150/thno.33904
  129. Y. Zhang, S. Liu, W. Guo, M. Wang, C. Hao et al., Human umbilical cord wharton’s jelly mesenchymal stem cells combined with an acellular cartilage extracellular matrix scaffold improve cartilage repair compared with microfracture in a caprine model. Osteoarthritis Cartil. 26(7), 954–965 (2018). https://doi.org/10.1016/j.joca.2018.01.019
  130. S. Zahiri, E. Masaeli, E. Poorazizi, M.H. Nasr-Esfahani, Chondrogenic response in presence of cartilage extracellular matrix nanops. J. Biomed. Mater. Res. Part A 106(9), 2463–2471 (2018). https://doi.org/10.1002/jbm.a.36440
  131. D. Shi, X. Xu, Y. Ye, K. Song, Y. Cheng et al., Photo-cross-linked scaffold with kartogenin-encapsulated nanops for cartilage regeneration. ACS Nano 10(1), 1292–1299 (2016). https://doi.org/10.1021/acsnano.5b06663
  132. W. Zhang, C. Ling, A. Zhang, H. Liu, Y. Jiang et al., An all-silk-derived functional nanosphere matrix for sequential biomolecule delivery and in situ osteochondral regeneration. Bioact. Mater. 5(4), 832–843 (2020). https://doi.org/10.1016/j.bioactmat.2020.05.003
  133. J. Shi, X. Zhang, J. Zhu, Y. Pi, X. Hu et al., Nanop delivery of the bone morphogenetic protein 4 gene to adipose-derived stem cells promotes articular cartilage repair in vitro and in vivo. Arthrosc.: J. Arthrosc. Relat. Surg.: Off. Publ. Arthrosc. Assoc. N. Am. Int. Arthrosc. Assoc. 29(12), 2001-2011.e2002 (2013). https://doi.org/10.1016/j.arthro.2013.09.076
  134. J. Li, Z. Li, D. Chu, L. Jin, X. Zhang, Fabrication and biocompatibility of core-shell structured magnetic fibrous scaffold. J. Biomed. Nanotechnol. 15(3), 500–506 (2019). https://doi.org/10.1166/jbn.2019.2701
  135. Z. Li, D. Chu, G. Chen, L. Shi, L. Jin et al., Biocompatible and biodegradable 3d double-network fibrous scaffold for excellent cell growth. J. Biomed. Nanotechnol. 15(11), 2209–2215 (2019). https://doi.org/10.1166/jbn.2019.2846
  136. R. Huang, X. Chen, Y. Dong, X. Zhang, Y. Wei et al., Mxene composite nanofibers for cell culture and tissue engineering. ACS Appl. Bio. Mater. 3(4), 2125–2131 (2020). https://doi.org/10.1021/acsabm.0c00007
  137. C. Boyer, L. Figueiredo, R. Pace, J. Lesoeur, T. Rouillon et al., Laponite nanop-associated silated hydroxypropylmethyl cellulose as an injectable reinforced interpenetrating network hydrogel for cartilage tissue engineering. Acta Biomater. (2018). https://doi.org/10.1016/j.actbio.2017.11.027
  138. H. Meng, Q. Quan, X. Yuan, Y. Zheng, J. Peng et al., Diffusion of neutral solutes within human osteoarthritic cartilage: effect of loading patterns. J. Orthop. Transl. 22, 58–66 (2020). https://doi.org/10.1016/j.jot.2019.10.013
  139. Z. Sun, E. Feeney, Y. Guan, S.G. Cook, D. Gourdon et al., Boundary mode lubrication of articular cartilage with a biomimetic diblock copolymer. Proc. Natl. Acad. Sci. U. S. A. 116(25), 12437–12441 (2019). https://doi.org/10.1073/pnas.1900716116
  140. Y. Yan, T. Sun, H. Zhang, X. Ji, Y. Sun et al., Euryale ferox seed-inspired superlubricated nanops for treatment of osteoarthritis. Adv. Funct. Mater. 29(4), 1807559 (2019). https://doi.org/10.1002/adfm.201807559
  141. P.M. van der Kraan, W.B. van den Berg, Chondrocyte hypertrophy and osteoarthritis: role in initiation and progression of cartilage degeneration? Osteoarthritis Cartil. 20(3), 223–232 (2012). https://doi.org/10.1016/j.joca.2011.12.003
  142. S. Chen, P. Fu, R. Cong, H. Wu, M. Pei, Strategies to minimize hypertrophy in cartilage engineering and regeneration. Genes Dis. 2(1), 76–95 (2015). https://doi.org/10.1016/j.gendis.2014.12.003
  143. H. Sasaki, K. Takayama, T. Matsushita, K. Ishida, S. Kubo et al., Autophagy modulates osteoarthritis-related gene expression in human chondrocytes. Arthritis Rheum. 64(6), 1920–1928 (2012). https://doi.org/10.1002/art.34323
  144. R.F. Loeser, J.A. Collins, B.O. Diekman, Ageing and the pathogenesis of osteoarthritis. Nat. Rev. Rheumatol. 12(7), 412–420 (2016). https://doi.org/10.1038/nrrheum.2016.65
  145. G. Zhong, X. Yang, X. Jiang, A. Kumar, H. Long et al., Dopamine-melanin nanops scavenge reactive oxygen and nitrogen species and activate autophagy for osteoarthritis therapy. Nanoscale 11(24), 11605–11616 (2019). https://doi.org/10.1039/c9nr03060c
  146. H. Yan, X. Duan, H. Pan, N. Holguin, M.F. Rai et al., Suppression of NF-κB activity via nanop-based sirna delivery alters early cartilage responses to injury. Proc. Natl. Acad. Sci. U. S. A. 113(41), E6199-e6208 (2016). https://doi.org/10.1073/pnas.1608245113
  147. P.G. Conaghan, A.D. Cook, J.A. Hamilton, P.P. Tak, Therapeutic options for targeting inflammatory osteoarthritis pain. Nat. Rev. Rheumatol. 15(6), 355–363 (2019). https://doi.org/10.1038/s41584-019-0221-y
  148. H.-F. Zhou, H. Yan, A. Senpan, S.A. Wickline, D. Pan et al., Suppression of inflammation in a mouse model of rheumatoid arthritis using targeted lipase-labile fumagillin prodrug nanops. Biomaterials 33(33), 8632–8640 (2012). https://doi.org/10.1016/j.biomaterials.2012.08.005
  149. M. Kapoor, J. Martel-Pelletier, D. Lajeunesse, J.P. Pelletier, H. Fahmi, Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat. Rev. Rheumatol. 7(1), 33–42 (2011). https://doi.org/10.1038/nrrheum.2010.196
  150. R.E. Whitmire, D.S. Wilson, A. Singh, M.E. Levenston, N. Murthy et al., Self-assembling nanops for intra-articular delivery of anti-inflammatory proteins. Biomaterials 33(30), 7665–7675 (2012). https://doi.org/10.1016/j.biomaterials.2012.06.101
  151. H. Lee, M.Y. Lee, S.H. Bhang, B.S. Kim, Y.S. Kim et al., Hyaluronate-gold nanop/tocilizumab complex for the treatment of rheumatoid arthritis. ACS Nano 8(5), 4790–4798 (2014). https://doi.org/10.1021/nn500685h
  152. M.R. Bhalekar, P.G. Upadhaya, A.R. Madgulkar, Fabrication and efficacy evaluation of chloroquine nanops in cfa-induced arthritic rats using TNF-α elisa. Eur. J. Pharm. Sci. 84, 1–8 (2016). https://doi.org/10.1016/j.ejps.2016.01.009
  153. J.B. Lin, S. Poh, A. Panitch, Controlled release of anti-inflammatory peptides from reducible thermosensitive nanops suppresses cartilage inflammation. Nanomed. Nanotechnol. Biol. Med. 12(7), 2095–2100 (2016). https://doi.org/10.1016/j.nano.2016.05.010
  154. R.L. Bartlett 2nd., S. Sharma, A. Panitch, Cell-penetrating peptides released from thermosensitive nanops suppress pro-inflammatory cytokine response by specifically targeting inflamed cartilage explants. Nanomedicine 9(3), 419–427 (2013). https://doi.org/10.1016/j.nano.2012.09.003
  155. J. McMasters, S. Poh, J.B. Lin, A. Panitch, Delivery of anti-inflammatory peptides from hollow PEGylated poly(NIPAM) nanops reduces inflammation in an ex vivo osteoarthritis model. J. Control. Release 258, 161–170 (2017). https://doi.org/10.1016/j.jconrel.2017.05.008
  156. L. Yuan, R.-X. Liao, Y.-Y. Lin, Y. Jiang, O. Wang et al., Safety and efficacy of cyclooxygenase-2 inhibition for treatment of primary hypertrophic osteoarthropathy: a single-arm intervention trial. J. Orthop. Transl. 18, 109–118 (2018). https://doi.org/10.1016/j.jot.2018.10.001
  157. M.J. Kim, J.S. Park, S.J. Lee, J. Jang, J.S. Park et al., Notch1 targeting siRNA delivery nanops for rheumatoid arthritis therapy. J. Control. Release 216, 140–148 (2015). https://doi.org/10.1016/j.jconrel.2015.08.025
  158. P. Lepetsos, A.G. Papavassiliou, Ros/oxidative stress signaling in osteoarthritis. Biochim. Biophys. Acta 1862(4), 576–591 (2016). https://doi.org/10.1016/j.bbadis.2016.01.003
  159. Y.C. Cheuk, S.C. Fu, S.W. Mok, K.K. Ho, L.K. Hung et al., Intra-articular injection of an antioxidant formulation did not improve structural degeneration in a rat model of post-traumatic osteoarthritis. J. Orthop. Transl. 8, 25–31 (2017). https://doi.org/10.1016/j.jot.2016.08.001
  160. W. Li, L. Cai, Y. Zhang, L. Cui, G. Shen, Intra-articular resveratrol injection prevents osteoarthritis progression in a mouse model by activating SIRT1 and thereby silencing HIF-2α. J. Orthop. Res. 33(7), 1061–1070 (2015). https://doi.org/10.1002/jor.22859
  161. S. Kumar, I.M. Adjei, S.B. Brown, O. Liseth, B. Sharma, Manganese dioxide nanops protect cartilage from inflammation-induced oxidative stress. Biomaterials 224, 119467 (2019). https://doi.org/10.1016/j.biomaterials.2019.119467
  162. L. Zhang, J. Hu, K.A. Athanasiou, The role of tissue engineering in articular cartilage repair and regeneration. Crit. Rev. Biomed. Eng. 37(1–2), 1–57 (2009). https://doi.org/10.1615/critrevbiomedeng.v37.i1-2.10
  163. S. Zhang, B. Hu, W. Liu, P. Wang, X. Lv et al., Articular cartilage regeneration: the role of endogenous mesenchymal stem/progenitor cell recruitment and migration. Semin. Arthritis Rheum. 50(2), 198–208 (2020). https://doi.org/10.1016/j.semarthrit.2019.11.001
  164. N. Dunker, K. Krieglstein, Targeted mutations of transforming growth factor-beta genes reveal important roles in mouse development and adult homeostasis. Eur. J. Biochem. 267(24), 6982–6988 (2000). https://doi.org/10.1046/j.1432-1327.2000.01825.x
  165. J. Shen, J. Li, B. Wang, H. Jin, M. Wang et al., Deletion of the transforming growth factor beta receptor type ii gene in articular chondrocytes leads to a progressive osteoarthritis-like phenotype in mice. Arthritis Rheum. 65(12), 3107–3119 (2013). https://doi.org/10.1002/art.38122
  166. T. Li, S. Chubinskaya, A. Esposito, X. Jin, L. Tagliafierro et al., Tgf-beta type 2 receptor-mediated modulation of the il-36 family can be therapeutically targeted in osteoarthritis. Sci. Transl. Med. (2019). https://doi.org/10.1126/scitranslmed.aan2585
  167. L.M. Cross, J.K. Carrow, X. Ding, K.A. Singh, A.K. Gaharwar, Sustained and prolonged delivery of protein therapeutics from two-dimensional nanosilicates. ACS Appl. Mater. Interfaces 11(7), 6741–6750 (2019). https://doi.org/10.1021/acsami.8b17733
  168. X. Sun, J. Wang, Y. Wang, C. Huang, C. Yang et al., Scaffold with orientated microtubule structure containing polylysine-heparin sodium nanops for the controlled release of tgf-β1 in cartilage tissue engineering. ACS Appl. Bio Mater. 1(6), 2030–2040 (2018). https://doi.org/10.1021/acsabm.8b00523
  169. F.Y. Wei, J.K. Lee, L. Wei, F. Qu, J.Z. Zhang, Correlation of insulin-like growth factor 1 and osteoarthritic cartilage degradation: a spontaneous osteoarthritis in guinea-pig. Eur. Rev. Med. Pharmacol. Sci. 21(20), 4493–4500 (2017)
  170. K.J. Ekenstedt, W.E. Sonntag, R.F. Loeser, B.R. Lindgren, C.S. Carlson, Effects of chronic growth hormone and insulin-like growth factor 1 deficiency on osteoarthritis severity in rat knee joints. Arthritis Rheum. 54(12), 3850–3858 (2006). https://doi.org/10.1002/art.22254
  171. J. Pasold, K. Zander, B. Heskamp, C. Grüttner, F. Lüthen et al., Positive impact of IGF-1-coupled nanops on the differentiation potential of human chondrocytes cultured on collagen scaffolds. Int. J. Nanomed. 10, 1131–1143 (2015). https://doi.org/10.2147/ijn.S72872
  172. L. Longobardi, L. O’Rear, S. Aakula, B. Johnstone, K. Shimer et al., Effect of IGF-i in the chondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF-beta signaling. J. Bone Miner. Res. 21(4), 626–636 (2006). https://doi.org/10.1359/jbmr.051213
  173. J. Frisch, A. Rey-Rico, J.K. Venkatesan, G. Schmitt, H. Madry et al., Chondrogenic differentiation processes in human bone marrow aspirates upon raav-mediated gene transfer and overexpression of the insulin-like growth factor i. Tissue Eng. Part A 21(17–18), 2460–2471 (2015). https://doi.org/10.1089/ten.TEA.2014.0679
  174. M. Zhang, Q. Zhou, Q.Q. Liang, C.G. Li, J.D. Holz et al., IGF-1 regulation of type ii collagen and mmp-13 expression in rat endplate chondrocytes via distinct signaling pathways. Osteoarthritis Cartil. 17(1), 100–106 (2009). https://doi.org/10.1016/j.joca.2008.05.007
  175. J.A. Tyler, Insulin-like growth factor 1 can decrease degradation and promote synthesis of proteoglycan in cartilage exposed to cytokines. Biochem. J. 260(2), 543–548 (1989). https://doi.org/10.1042/bj2600543
  176. J.L. Ellsworth, J. Berry, T. Bukowski, J. Claus, A. Feldhaus et al., Fibroblast growth factor-18 is a trophic factor for mature chondrocytes and their progenitors. Osteoarthritis Cartil. 10(4), 308–320 (2002). https://doi.org/10.1053/joca.2002.0514
  177. E.E. Moore, A.M. Bendele, D.L. Thompson, A. Littau, K.S. Waggie et al., Fibroblast growth factor-18 stimulates chondrogenesis and cartilage repair in a rat model of injury-induced osteoarthritis. Osteoarthritis Cartil. 13(7), 623–631 (2005). https://doi.org/10.1016/j.joca.2005.03.003
  178. S.L. Chia, Y. Sawaji, A. Burleigh, C. McLean, J. Inglis et al., Fibroblast growth factor 2 is an intrinsic chondroprotective agent that suppresses adamts-5 and delays cartilage degradation in murine osteoarthritis. Arthritis Rheum. 60(7), 2019–2027 (2009). https://doi.org/10.1002/art.24654
  179. X. Wang, P.A. Manner, A. Horner, L. Shum, R.S. Tuan et al., Regulation of MMP-13 expression by RUNX2 and FGF2 in osteoarthritic cartilage. Osteoarthritis Cartil. 12(12), 963–973 (2004). https://doi.org/10.1016/j.joca.2004.08.008
  180. H.J. Im, X. Li, P. Muddasani, G.H. Kim, F. Davis et al., Basic fibroblast growth factor accelerates matrix degradation via a neuro-endocrine pathway in human adult articular chondrocytes. J. Cell. Physiol. 215(2), 452–463 (2008). https://doi.org/10.1002/jcp.21317
  181. D. Yan, D. Chen, S.M. Cool, A.J. van Wijnen, K. Mikecz et al., Fibroblast growth factor receptor 1 is principally responsible for fibroblast growth factor 2-induced catabolic activities in human articular chondrocytes. Arthritis Res. Ther. 13(4), R130 (2011). https://doi.org/10.1186/ar3441
  182. N.D. Miljkovic, G.M. Cooper, K.G. Marra, Chondrogenesis, bone morphogenetic protein-4 and mesenchymal stem cells. Osteoarthritis Cartil. 16(10), 1121–1130 (2008). https://doi.org/10.1016/j.joca.2008.03.003
  183. C. Wang, R.M. Silverman, J. Shen, R.J. O’Keefe, Distinct metabolic programs induced by TGF-β1 and bmp2 in human articular chondrocytes with osteoarthritis. J. Orthop. Transl. 12, 66–73 (2018). https://doi.org/10.1016/j.jot.2017.12.004
  184. B.S. Yoon, K.M. Lyons, Multiple functions of BMPS in chondrogenesis. J. Cell. Biochem. 93(1), 93–103 (2004). https://doi.org/10.1002/jcb.20211
  185. K. Johnson, S. Zhu, M.S. Tremblay, J.N. Payette, J. Wang et al., A stem cell-based approach to cartilage repair. Science 336(6082), 717–721 (2012). https://doi.org/10.1126/science.1215157
  186. Y. Hong, Y. Han, J. Wu, X. Zhao, J. Cheng et al., Chitosan modified Fe3O4/KGN self-assembled nanoprobes for osteochondral MR diagnose and regeneration. Theranostics 10(12), 5565–5577 (2020). https://doi.org/10.7150/thno.43569
  187. S.P. Henry, S. Liang, K.C. Akdemir, B. de Crombrugghe, The postnatal role of SOX9 in cartilage. J. Bone Miner. Res. 27(12), 2511–2525 (2012). https://doi.org/10.1002/jbmr.1696
  188. W. Li, J. Lin, Z. Wang, S. Ren, X. Wu et al., Bevacizumab tested for treatment of knee osteoarthritis via inhibition of synovial vascular hyperplasia in rabbits. J. Orthop. Transl. 19, 38–46 (2019). https://doi.org/10.1016/j.jot.2019.04.002
  189. C.L. Wu, N.S. Harasymowicz, M.A. Klimak, K.H. Collins, F. Guilak, The role of macrophages in osteoarthritis and cartilage repair. Osteoarthritis Cartil. (2020). https://doi.org/10.1016/j.joca.2019.12.007
  190. S. Li, W. Cong, A. Hakamivala, Y. Huang, J. Borrelli et al., Hyaluronic acid-based optical probe for the diagnosis of human osteoarthritic cartilage. Nanotheranostics 2(4), 347–359 (2018). https://doi.org/10.7150/ntno.26119
  191. Y. Yang, L. Guo, Z. Wang, P. Liu, X. Liu et al., Targeted silver nanops for rheumatoid arthritis therapy via macrophage apoptosis and re-polarization. Biomaterials 264, 120390 (2021). https://doi.org/10.1016/j.biomaterials.2020.120390
  192. L. Ma, T.W. Liu, M.A. Wallig, I.T. Dobrucki, L.W. Dobrucki et al., Efficient targeting of adipose tissue macrophages in obesity with polysaccharide nanocarriers. ACS Nano 10(7), 6952–6962 (2016). https://doi.org/10.1021/acsnano.6b02878
  193. G. Hu, M. Guo, J. Xu, F. Wu, J. Fan et al., Nanops targeting macrophages as potential clinical therapeutic agents against cancer and inflammation. Front. Immunol. 10, 1998–1998 (2019). https://doi.org/10.3389/fimmu.2019.01998
  194. M. Ovais, M. Guo, C. Chen, Tailoring nanomaterials for targeting tumor-associated macrophages. Adv. Mater. 31(19), e1808303 (2019). https://doi.org/10.1002/adma.201808303
  195. J. Yang, X. Zhang, C. Liu, Z. Wang, L. Deng, C. Feng, W. Tao, X. Xu, W. Cui, Biologically modified nanops as theranostic bionanomaterials. Prog. Mater. Sci. 118, 100768 (2021). https://doi.org/10.1016/j.pmatsci.2020.100768
  196. R. Li, Y. He, Y. Zhu, L. Jiang, S. Zhang et al., Route to rheumatoid arthritis by macrophage-derived microvesicle-coated nanops. Nano Lett. 19(1), 124–134 (2019). https://doi.org/10.1021/acs.nanolett.8b03439
  197. Q. Zhang, D. Dehaini, Y. Zhang, J. Zhou, X. Chen et al., Neutrophil membrane-coated nanops inhibit synovial inflammation and alleviate joint damage in inflammatory arthritis. Nat. Nanotechnol. 13(12), 1182–1190 (2018). https://doi.org/10.1038/s41565-018-0254-4
  198. D.M. Findlay, J.S. Kuliwaba, Bone-cartilage crosstalk: a conversation for understanding osteoarthritis. Bone Res. 4, 16028 (2016). https://doi.org/10.1038/boneres.2016.28
  199. R.J. Lories, F.P. Luyten, The bone-cartilage unit in osteoarthritis. Nat. Rev. Rheumatol. 7(1), 43–49 (2011). https://doi.org/10.1038/nrrheum.2010.197
  200. L. Chu, Z. He, X. Qu, X. Liu, W. Zhang et al., Different subchondral trabecular bone microstructure and biomechanical properties between developmental dysplasia of the hip and primary osteoarthritis. J. Orthop. Transl. 22, 50–57 (2020). https://doi.org/10.1016/j.jot.2019.09.001
  201. G. Li, L. Chen, Q. Zheng, Y. Ma, C. Zhang et al., Subchondral bone deterioration in femoral heads in patients with osteoarthritis secondary to hip dysplasia: a case–control study. J. Orthop. Transl. 24, 190–197 (2019). https://doi.org/10.1016/j.jot.2019.10.014
  202. S. Zhu, J. Zhu, G. Zhen, Y. Hu, S. An et al., Subchondral bone osteoclasts induce sensory innervation and osteoarthritis pain. J. Clin. Invest. 129(3), 1076–1093 (2019). https://doi.org/10.1172/JCI121561
  203. R. Kc, X. Li, J.S. Kroin, Z. Liu, D. Chen et al., PKCδ null mutations in a mouse model of osteoarthritis alter osteoarthritic pain independently of joint pathology by augmenting NGF/TRKA-induced axonal outgrowth. Ann. Rheum. Dis. 75(12), 2133–2141 (2016). https://doi.org/10.1136/annrheumdis-2015-208444
  204. M. Ikeuchi, Q. Wang, M. Izumi, T. Tani, Nociceptive sensory innervation of the posterior cruciate ligament in osteoarthritic knees. Arch. Orthop. Trauma Surg. 132(6), 891–895 (2012). https://doi.org/10.1007/s00402-012-1478-7
  205. A.M. Malfait, T.J. Schnitzer, Towards a mechanism-based approach to pain management in osteoarthritis. Nat. Rev. Rheumatol. 9(11), 654–664 (2013). https://doi.org/10.1038/nrrheum.2013.138
  206. M.P. Kashyap, C. Roberts, M. Waseem, P. Tyagi, Drug targets in neurotrophin signaling in the central and peripheral nervous system. Mol. Neurobiol. 55(8), 6939–6955 (2018). https://doi.org/10.1007/s12035-018-0885-3
  207. S. Takano, K. Uchida, G. Inoue, M. Miyagi, J. Aikawa et al., Nerve growth factor regulation and production by macrophages in osteoarthritic synovium. Clin. Exp. Immunol. 190(2), 235–243 (2017). https://doi.org/10.1111/cei.13007
  208. P. Jayabalan, T.J. Schnitzer, Tanezumab in the treatment of chronic musculoskeletal conditions. Expert Opin. Biol. Ther. 17(2), 245–254 (2017). https://doi.org/10.1080/14712598.2017.1271873
  209. L.N. Nwosu, P.I. Mapp, V. Chapman, D.A. Walsh, Blocking the tropomyosin receptor kinase a (TRKA) receptor inhibits pain behaviour in two rat models of osteoarthritis. Ann. Rheum. Dis. 75(6), 1246–1254 (2016). https://doi.org/10.1136/annrheumdis-2014-207203
  210. M.S.M. Persson, J. Stocks, D.A. Walsh, M. Doherty, W. Zhang, The relative efficacy of topical non-steroidal anti-inflammatory drugs and capsaicin in osteoarthritis: a network meta-analysis of randomised controlled trials. Osteoarthritis Cartil. 26(12), 1575–1582 (2018). https://doi.org/10.1016/j.joca.2018.08.008
  211. P.I. Mapp, D.A. Walsh, Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis. Nat. Rev. Rheumatol. 8(7), 390–398 (2012). https://doi.org/10.1038/nrrheum.2012.80
  212. S. Ashraf, D.A. Walsh, Angiogenesis in osteoarthritis. Curr. Opin. Rheumatol. 20(5), 573–580 (2008). https://doi.org/10.1097/BOR.0b013e3283103d12
  213. M.P. Murphy, L.S. Koepke, M.T. Lopez, X. Tong, T.H. Ambrosi et al., Articular cartilage regeneration by activated skeletal stem cells. Nat. Med. 26(10), 1583–1592 (2020). https://doi.org/10.1038/s41591-020-1013-2
  214. C.J. Avraamides, B. Garmy-Susini, J.A. Varner, Integrins in angiogenesis and lymphangiogenesis. Nat. Rev. Cancer 8(8), 604–617 (2008). https://doi.org/10.1038/nrc2353
  215. P. Mukherjee, R. Bhattacharya, P. Wang, L. Wang, S. Basu et al., Antiangiogenic properties of gold nanops. Clin. Cancer Res. 11(9), 3530–3534 (2005). https://doi.org/10.1158/1078-0432.Ccr-04-2482
  216. T. Yang, Q. Yao, F. Cao, Q. Liu, B. Liu et al., Silver nanops inhibit the function of hypoxia-inducible factor-1 and target genes: Insight into the cytotoxicity and antiangiogenesis. Int. J. Nanomed. 11, 6679–6692 (2016). https://doi.org/10.2147/ijn.S109695
  217. S. Gurunathan, K.J. Lee, K. Kalishwaralal, S. Sheikpranbabu, R. Vaidyanathan et al., Antiangiogenic properties of silver nanops. Biomaterials 30(31), 6341–6350 (2009). https://doi.org/10.1016/j.biomaterials.2009.08.008
  218. J. Kim, A.C. Mirando, A.S. Popel, J.J. Green, Gene delivery nanops to modulate angiogenesis. Adv. Drug Deliv. Rev. 119, 20–43 (2017). https://doi.org/10.1016/j.addr.2016.11.003
  219. M.A. Greene, R.F. Loeser, Aging-related inflammation in osteoarthritis. Osteoarthritis Cartil. 23(11), 1966–1971 (2015). https://doi.org/10.1016/j.joca.2015.01.008
  220. J. Lieberthal, N. Sambamurthy, C.R. Scanzello, Inflammation in joint injury and post-traumatic osteoarthritis. Osteoarthritis Cartil. 23(11), 1825–1834 (2015). https://doi.org/10.1016/j.joca.2015.08.015
  221. C.C. Wu, W.H. Chen, B. Zao, P.L. Lai, T.C. Lin et al., Regenerative potentials of platelet-rich plasma enhanced by collagen in retrieving pro-inflammatory cytokine-inhibited chondrogenesis. Biomaterials 32(25), 5847–5854 (2011). https://doi.org/10.1016/j.biomaterials.2011.05.002
  222. C. Gao, Y. Wang, Z. Ye, Z. Lin, X. Ma et al., Biomedical micro-/nanomotors: from overcoming biological barriers to in vivo imaging. Adv. Mater. 33(6), e2000512 (2021). https://doi.org/10.1002/adma.202000512
  223. P. Mi, Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics. Theranostics 10(10), 4557–4588 (2020). https://doi.org/10.7150/thno.38069
  224. S. Mura, J. Nicolas, P. Couvreur, Stimuli-responsive nanocarriers for drug delivery. Nat. Mater. 12(11), 991–1003 (2013). https://doi.org/10.1038/nmat3776
  225. S. Jafari, L.O. Mair, S. Chowdhury, A. Nacev, R. Hilaman et al., Magnetically targeted delivery through cartilage. AIP Adv. 8(5), 056717 (2018). https://doi.org/10.1063/1.5006156
  226. J.-Y. Su, S.-H. Chen, Y.-P. Chen, W.-C. Chen, Evaluation of magnetic nanop-labeled chondrocytes cultivated on a type ii collagen-chitosan/poly(lactic-co-glycolic) acid biphasic scaffold. Int. J. Mol. Sci. 18(1), 87 (2017). https://doi.org/10.3390/ijms18010087
  227. B. Son, H.D. Kim, M. Kim, J.A. Kim, J. Lee et al., Physical stimuli-induced chondrogenic differentiation of mesenchymal stem cells using magnetic nanops. Adv. Healthc. Mater. 4(9), 1339–1347 (2015). https://doi.org/10.1002/adhm.201400835
  228. X.-Y. Zhou, X.-X. Zhang, G.-Y. Yu, Z.-C. Zhang, F. Wang et al., Effects of low-intensity pulsed ultrasound on knee osteoarthritis: A meta-analysis of randomized clinical trials. Biomed Res. Int. 2018, 7469197–7469197 (2018). https://doi.org/10.1155/2018/7469197
  229. T. Nishida, S. Kubota, E. Aoyama, N. Yamanaka, K.M. Lyons et al., Low-intensity pulsed ultrasound (LIPUS) treatment of cultured chondrocytes stimulates production of ccn family protein 2 (CCN2), a protein involved in the regeneration of articular cartilage: Mechanism underlying this stimulation. Osteoarthritis Cartil. 25(5), 759–769 (2017). https://doi.org/10.1016/j.joca.2016.10.003
  230. D. Gao, T. Chen, S. Chen, X. Ren, Y. Han et al., Targeting hypoxic tumors with hybrid nanobullets for oxygen-independent synergistic photothermal and thermodynamic therapy. Nano-Micro Lett. 13(1), 99 (2021). https://doi.org/10.1007/s40820-021-00616-4
  231. Z. Yang, D. Gao, X. Guo, L. Jin, J. Zheng et al., Fighting immune cold and reprogramming immunosuppressive tumor microenvironment with red blood cell membrane-camouflaged nanobullets. ACS Nano 14(12), 17442–17457 (2020). https://doi.org/10.1021/acsnano.0c07721
  232. D. Gao, X. Guo, X. Zhang, S. Chen, Y. Wang et al., Multifunctional phototheranostic nanomedicine for cancer imaging and treatment. Mater. Today Bio 5, 100035 (2020). https://doi.org/10.1016/j.mtbio.2019.100035
  233. J. You, R. Zhang, C. Xiong, M. Zhong, M. Melancon et al., Effective photothermal chemotherapy using doxorubicin-loaded gold nanospheres that target EPHB4 receptors in tumors. Cancer Res. 72(18), 4777–4786 (2012). https://doi.org/10.1158/0008-5472.Can-12-1003
  234. A.W. Visser, R. de Mutsert, S. le Cessie, M. den Heijer, F.R. Rosendaal et al., The relative contribution of mechanical stress and systemic processes in different types of osteoarthritis: the neo study. Ann. Rheum. Dis. 74(10), 1842–1847 (2015). https://doi.org/10.1136/annrheumdis-2013-205012
  235. M.N. Holme, I.A. Fedotenko, D. Abegg, J. Althaus, L. Babel et al., Shear-stress sensitive lenticular vesicles for targeted drug delivery. Nat. Nanotechnol. 7(8), 536–543 (2012). https://doi.org/10.1038/nnano.2012.84
  236. R. Rajamanickam, S. Baek, K. Gwon, Y. Hwang, K. Shin et al., Mechanical stimuli responsive and highly elastic biopolymer/nanop hybrid microcapsules for controlled release. J. Mater. Chem. B 4(24), 4278–4286 (2016). https://doi.org/10.1039/c6tb00410e
  237. M. Deloney, K. Smart, B.A. Christiansen, A. Panitch, Thermoresponsive, hollow, degradable core-shell nanops for intra-articular delivery of anti-inflammatory peptide. J. Control. Release 323, 47–58 (2020). https://doi.org/10.1016/j.jconrel.2020.04.007
  238. Y. Wang, D. Gao, Y. Liu, X. Guo, S. Chen et al., Immunogenic-cell-killing and immunosuppression-inhibiting nanomedicine. Bioact. Mater. 6(6), 1513–1527 (2021). https://doi.org/10.1016/j.bioactmat.2020.11.016
  239. S.M. Horvath, J.L. Hollander, Intra-articular temperature as a measure of joint reaction. J. Clin. Invest. 28(3), 469–473 (1949). https://doi.org/10.1172/jci102092
  240. N.A. Cummings, G.L. Nordby, Measurement of synovial fluid pH in normal and arthritic knees. Arthritis Rheum. 9(1), 47–56 (1966). https://doi.org/10.1002/art.1780090106
  241. S. Khanal, U. Adhikari, N.P. Rijal, S.R. Bhattarai, J. Sankar et al., pH-responsive plga nanop for controlled payload delivery of diclofenac sodium. J. Funct. Biol. 7(3), 21 (2016). https://doi.org/10.3390/jfb7030021
  242. M.F. Chung, W.T. Chia, W.L. Wan, Y.J. Lin, H.W. Sung, Controlled release of an anti-inflammatory drug using an ultrasensitive ros-responsive gas-generating carrier for localized inflammation inhibition. J. Am. Chem. Soc. 137(39), 12462–12465 (2015). https://doi.org/10.1021/jacs.5b08057
  243. D. Olszewska-Slonina, S. Jung, D. Matewski, K.J. Olszewski, E. Krzyzynska-Malinowska et al., Lysosomal enzymes in serum and synovial fluid in patients with osteoarthritis. Scand. J. Clin. Lab. Invest. 75(2), 145–151 (2015). https://doi.org/10.3109/00365513.2014.992946
  244. Z. Jia, L. Song, F. Zang, J. Song, W. Zhang et al., Active-target t1-weighted MR imaging of tiny hepatic tumor via RGD modified ultra-small Fe3O4 nanoprobes. Theranostics 6(11), 1780–1791 (2016). https://doi.org/10.7150/thno.14280
  245. Y.M. Soshnikova, S.G. Roman, N.A. Chebotareva, O.I. Baum, M.V. Obrezkova et al., Starch-modified magnetite nanops for impregnation into cartilage. J. Nanopart. Res. 15(11), 2092 (2013). https://doi.org/10.1007/s11051-013-2092-5
  246. C. Bai, Z. Jia, L. Song, W. Zhang, Y. Chen et al., Time-dependent t1–t2 switchable magnetic resonance imaging realized by c (RGDYK) modified ultrasmall Fe3O4 nanoprobes. Adv. Funct. Mater. 28(32), 1802281 (2018). https://doi.org/10.1002/adfm.201802281
  247. A.J. Mieszawska, W.J.M. Mulder, Z.A. Fayad, D.P. Cormode, Multifunctional gold nanops for diagnosis and therapy of disease. Mol. Pharm. 10(3), 831–847 (2013). https://doi.org/10.1021/mp3005885
  248. S. Peng, Q. Zheng, X. Zhang, L. Dai, J. Zhu et al., Detection of adamts-4 activity using a fluorogenic peptide-conjugated au nanop probe in human knee synovial fluid. ACS Appl. Mater. Interfaces 5(13), 6089–6096 (2013). https://doi.org/10.1021/am400854z
  249. V.C. Pierre, M. Botta, S. Aime, K.N. Raymond, Substituent effects on Gd(iii)-based MRI contrast agents: optimizing the stability and selectivity of the complex and the number of coordinated water molecules. Inorg. Chem. 45(20), 8355–8364 (2006). https://doi.org/10.1021/ic061262q
  250. T. Kim, E. Momin, J. Choi, K. Yuan, H. Zaidi et al., Mesoporous silica-coated hollow manganese oxide nanops as positive t1 contrast agents for labeling and mri tracking of adipose-derived mesenchymal stem cells. J. Am. Chem. Soc. 133(9), 2955–2961 (2011). https://doi.org/10.1021/ja1084095
  251. P.H. Kuo, E. Kanal, A.K. Abu-Alfa, S.E. Cowper, Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiology 242(3), 647–649 (2007). https://doi.org/10.1148/radiol.2423061640
  252. J. Chen, J. Qi, C. Chen, J. Chen, L. Liu et al., Tocilizumab-conjugated polymer nanops for NIR-ii photoacoustic-imaging-guided therapy of rheumatoid arthritis. Adv. Mater. (2020). https://doi.org/10.1002/adma.202003399
  253. J. Ouyang, X. Ji, X. Zhang, C. Feng, Z. Tang et al., In situ sprayed NIR-responsive, analgesic black phosphorus-based gel for diabetic ulcer treatment. Proc. Natl. Acad. Sci. U. S. A. 117(46), 28667–28677 (2020). https://doi.org/10.1073/pnas.2016268117
  254. L. Jin, X. Guo, D. Gao, C. Wu, B. Hu et al., Nir-responsive mxene nanobelts for wound healing. NPG Asia Mater. 13(1), 24 (2021). https://doi.org/10.1038/s41427-021-00289-w
  255. P. Jin, C. Wiraja, J. Zhao, J. Zhang, L. Zheng et al., Nitric oxide nanosensors for predicting the development of osteoarthritis in rat model. ACS Appl. Mater. Interfaces 9(30), 25128–25137 (2017). https://doi.org/10.1021/acsami.7b06404
  256. L. Zhou, V.O. Gjvm, J. Malda, M.J. Stoddart, Y. Lai et al., Innovative tissue-engineered strategies for osteochondral defect repair and regeneration: Current progress and challenges. Adv. Healthc. Mater. (2020). https://doi.org/10.1002/adhm.202001008
  257. S.T. Grady, L. Britton, K. Hinrichs, A.J. Nixon, A.E. Watts, Persistence of fluorescent nanop-labelled bone marrow mesenchymal stem cells in vitro and after intra-articular injection. J. Tissue Eng. Regen. Med. 13(2), 191–202 (2019). https://doi.org/10.1002/term.2781
  258. J.M. Lee, B.S. Kim, H. Lee, G.I. Im, In vivo tracking of mesechymal stem cells using fluorescent nanops in an osteochondral repair model. Mol. Ther. 20(7), 1434–1442 (2012). https://doi.org/10.1038/mt.2012.60
  259. H. Markides, O. Kehoe, R.H. Morris, A.J. El. Haj, Whole body tracking of superparamagnetic iron oxide nanop-labelled cells–a rheumatoid arthritis mouse model. Stem Cell Res. Ther. 4(5), 126–126 (2013). https://doi.org/10.1186/scrt337
  260. J. Chen, F. Wang, Y. Zhang, X. Jin, L. Zhang et al., In vivo tracking of superparamagnetic iron oxide nanop labeled chondrocytes in large animal model. Ann. Biomed. Eng. 40(12), 2568–2578 (2012). https://doi.org/10.1007/s10439-012-0621-5
  261. G. Parekh, Y. Shi, J. Zheng, X. Zhang, S. Leporatti, Nano-carriers for targeted delivery and biomedical imaging enhancement. Ther. Deliv. 9(6), 451–468 (2018). https://doi.org/10.4155/tde-2018-0013
  262. P. Singh, S. Pandit, V. Mokkapati, A. Garg, V. Ravikumar et al., Gold nanops in diagnostics and therapeutics for human cancer. Int. J. Mol. Sci. (2018). https://doi.org/10.3390/ijms19071979
  263. M. Moglianetti, E. De. Luca, D. Pedone, R. Marotta, T. Catelani et al., Platinum nanozymes recover cellular ros homeostasis in an oxidative stress-mediated disease model. Nanoscale 8(6), 3739–3752 (2016). https://doi.org/10.1039/C5NR08358C
  264. Y. Vlamidis, V. Voliani, Bringing again noble metal nanops to the forefront of cancer therapy. Front. Bioeng. Biotechnol. 6, 143–143 (2018). https://doi.org/10.3389/fbioe.2018.00143
  265. K. Memarzadeh, A.S. Sharili, J. Huang, S.C. Rawlinson, R.P. Allaker, Nanoparticulate zinc oxide as a coating material for orthopedic and dental implants. J. Biomed. Mater. Res. Part A 103(3), 981–989 (2015). https://doi.org/10.1002/jbm.a.35241
  266. J.-L. Wang, J.-K. Xu, C. Hopkins, D.H.-K. Chow, L. Qin, Biodegradable magnesium-based implants in orthopedics-a general review and perspectives. Adv. Sci. 7(8), 1902443–1902443 (2020). https://doi.org/10.1002/advs.201902443
  267. J.H. Kim, J. Jeon, M. Shin, Y. Won, M. Lee et al., Regulation of the catabolic cascade in osteoarthritis by the zinc-ZIP8-MTF1 axis. Cell 156(4), 730–743 (2014). https://doi.org/10.1016/j.cell.2014.01.007
  268. H. Yao, J.K. Xu, N.Y. Zheng, J.L. Wang et al., Intra-articular injection of magnesium chloride attenuates osteoarthritis progression in rats. Osteoarthr. Cartil. 27(12), 1811–1821 (2019). https://doi.org/10.1016/j.joca.2019.08.007
  269. W.L. Wan, Y.J. Lin, P.C. Shih, Y.R. Bow, Q. Cui et al., An in situ depot for continuous evolution of gaseous H2 mediated by a magnesium passivation/activation cycle for treating osteoarthritis. Angew. Chem. Int. Ed. 57(31), 9875–9879 (2018). https://doi.org/10.1002/anie.201806159
  270. Z. Tang, N. Kong, X. Zhang, Y. Liu, P. Hu et al., A materials-science perspective on tackling covid-19. Nat. Rev. Mater. (2020). https://doi.org/10.1038/s41578-020-00247-y
  271. Z. Lei, W. Zhu, X. Zhang, X. Wang, P. Wu, Bio-inspired ionic skin for theranostics. Adv. Funct. Mater. 31(8), 2008020 (2021). https://doi.org/10.1002/adfm.202008020
  272. Z. Li, D. Chu, Y. Gao, L. Jin, X. Zhang et al., Biomimicry, biomineralization, and bioregeneration of bone using advanced three-dimensional fibrous hydroxyapatite scaffold. Mater. Today Adv. 3, 100014 (2019). https://doi.org/10.1016/j.mtadv.2019.100014
  273. C.L. Ventola, Progress in nanomedicine: approved and investigational nanodrugs. Pharm. Ther. 42(12), 742–755 (2017)
  274. W. Xinluan, L. Yuxiao, N.H. Helena, Y. Zhijun, Q. Ling, Systemic drug delivery systems for bone tissue regeneration—a mini review. Curr. Pharm. Des. 21(12), 1575–1583 (2015). https://doi.org/10.2174/1381612821666150115152841
  275. N. Bodick, J. Lufkin, C. Willwerth, A. Kumar, J. Bolognese et al., An intra-articular, extended-release formulation of triamcinolone acetonide prolongs and amplifies analgesic effect in patients with osteoarthritis of the knee: a randomized clinical trial. J. Bone Jt. Surg. Am. 97(11), 877–888 (2015). https://doi.org/10.2106/jbjs.N.00918
  276. S.G. Owen, H.W. Francis, M.S. Roberts, Disappearance kinetics of solutes from synovial fluid after intra-articular injection. Br. J. Clin. Pharmacol. 38(4), 349–355 (1994). https://doi.org/10.1111/j.1365-2125.1994.tb04365.x
  277. M.B. Goldring, J.-M. Dayer, S.R. Goldring, in Chapter 14—Osteoarthritis and the Immune System, eds. by J. Lorenzo, M.C. Horowitz, Y. Choi et al. (Academic Press, San Diego, 2016), pp. 257–269
Read More
Author biographies are not available.
Download this PDF file
PDF
Statistic
Read Counter : 9135 Download : 6908

Most read articles by the same author(s)